Abstract
Context
Undescended testes at birth may be caused by testosterone deficiency during fetal development. It is unclear whether the process of failed descent contributes to permanent endocrine impairment.
Objectives
To evaluate the impact of age at treatment of undescended testes on endocrine and spermatogenic testicular function in middle-aged men.
Patients and methods
Reproductive hormone and semen data of 357 men with previously undescended testes were evaluated with respect to age at correction of testicular position and compared to those of 709 controls with eutopic testes at birth and normozoospermia.
Results
Men with undescended testes had higher mean Luteinizing Hormone levels (p < 0.0001) and lower mean testosterone levels (p = 0.003) compared to controls. They also had lower bi-testicular volumes, higher Follicle Stimulating Hormone levels, and lower sperm concentrations (all p < 0.0001). Lowest mean sperm concentrations were found in subjects with bilateral undescended testes. Normal sperm concentrations were found in 21 % of cases (in 27 % of men with unilateral and in 12 % with bilateral undescended testes), while oligozoospermia was diagnosed in 44 %, and azoospermia in 35 % (in 28 % with unilateral, 46 % with bilateral undescended testes). Subjects with reduced semen quality had higher gonadotropin levels than those with normozoospermia. Age at correction (median: 6 years (1–39)) was inversely correlated with bi-testicular volumes and sperm concentrations, and positively correlated with FSH and LH, but not with serum testosterone.
Conclusion
Latent, rarely decompensated hypogonadism is a potential long-term consequence of undescended testes, besides infertility and testicular cancer, preferentially affecting subjects with delayed or unsuccessful correction of testicular position. Impaired Leydig cell function is likely to contribute to compromised fertility. These observations support correction of cryptorchidism during early infancy.
Similar content being viewed by others
References
G.S. Berkowitz, R.H. Lapinski, S.E. Dolgin, J.G. Gazella, C.A. Bodian, I.R. Holzman, Prevalence and natural history of cryptorchidism. Pediatrics 92, 44–49 (1993)
J.S. Barthold, R. Gonzalez, The epidemiology of congenital cryptorchidism, testicular ascent and orchiopexy. J. Urol. 170, 2396–2401 (2003)
J. Toppari, M. Kaleva, Maldescensus testis. Horm. Res. 51, 261–269 (1999)
P.A. Lee, L.A. O’Leary, N.J. Songer, M.T. Coughlin, M.F. Bellinger, R.E. LaPorte, Paternity after unilateral cryptorchidism: a controlled study. Pediatrics 98, 676–679 (1996)
P.A. Lee, M.F. Bellinger, M.T. Coughlin, Correlations among hormone levels, sperm parameters and paternity in formerly unilaterally cryptorchid men. J. Urol. 160, 1155–1158 (1998)
D. Cortes, J.M. Thorup, J. Visfeldt, Cryptorchidism: aspects of fertility and neoplasms. A study including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. Horm. Res. 55, 21–27 (2001)
M. Miller, M. Coughlin, P. Lee, Fertility after unilateral cryptorchidism: paternity, time to conception, pretreatment testicular location and sex hormone and sperm parameters. Horm. Res. 55, 249–253 (2001)
A. Giwercman, J. Grindsted, B. Hansen, Testicular cancer risk in boys with maldescended testis: a cohort study. J. Urol. 138, 1214–1216 (1987)
D. Pinczowksi, J.K. McLaughlin, G. Lackgren et al. Occurrence of testicular cancer in patients operated on for cryptorchidism and inguinal hernia. J. Urol. 146, 1291–1294 (1991)
A.J. Swerdlow, C.D. Higgins, M.C. Pike, Risk of testicular cancer in cohort of boys with cryptorchidism. BMJ. 314, 1507–1511 (1997)
A. Pettersson, L. Richiardi, A. Nordenskjold, M. Kaijser, O. Akre, Age at surgery for undescended testis and risk of testicular cancer. N. Engl. J. Med. 356, 1835–1841 (2007)
United Kingdom Testicular Cancer Study Group, Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. Br. Med. J. 308, 1393–1399 (2008)
N. Pitteloud, F.J. Hayes, A. Dwyer, P.A. Boepple, H. Lee, W.F. Crowley Jr, Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 87, 4128–4136 (2002)
J. Rohayem, N. Sinthofen, E. Nieschlag, S. Kliesch, M. Zitzmann, Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults. Andrology 4, 87–94 (2016)
J.M. Hutson, Testicular feminization: a model for testicular descent in mice and men. J. Pediatr. Surg. 21, 195–198 (1986)
J. Imperato-McGinley, L. Guerrero, T. Gautier, R.E. Peterson, Steroid 5a-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 186, 1213–1215 (1974)
M. Gotoh, K. Miyake, H. Mitsuya, A study of cryptorchidism. I. Light and electron microscopic study of Leydig’s cells in the testes of cryptorchid patients. Hinyokika. Kiyo. 30, 327–347 (1984)
D.S. Huff, F. Hadziselimović, H.M. Snyder 3rd, B. Blyth, J.W. Duckett, Early postnatal testicular maldevelopment in cryptorchidism. J. Urol. 146, 624–626 (1991)
D. Gendrel, M. Roger, J.C. Job, Plasma gonadotropin and testosterone values in infants with cryptorchidism. J. Pediatr. 97, 217–220 (1980)
J. Rabinovici, R.B. Jaffe, Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr. Rev. 11, 532–557 (1990)
J.C. Job, J.E. Toublanc, J.L. Chaussain, D. Gendrel, M. Roger, P. Canlorbe, The pituitary-gonadal axis in cryptorchid infants and children. Eur. J. Pediatr. 146, 2–5 (1987)
J.C. Job, J.E. Toublanc, J.L. Chaussain, D. Gendrel, P. Garnier, M. Roger, Endocrine and immunological findings in cryptorchid infants. Horm. Res. 30, 167–172 (1988)
F.H. Pierik, J.A. Deddens, A. Burdorf, S.M. de Muinck Keizer-Schrama, F.H. Jong, R.F. Weber, The hypothalamus-pituitary-testis axis in boys during the first six months of life: a comparison of cryptorchidism and hypospadias cases with controls. Int. J. Androl. 32, 453–461 (2009)
J.S. Barthold, J. Manson, V. Regan, X. Si, S.G. Hassink, M.T. Coughlin, P.A. Lee, Reproductive hormone levels in infants with cryptorchidism during postnatal activation of the pituitary-testicular axis. J. Urol. 172, 1736–1741 (2004)
A.M. Suomi, K.M. Main, M. Kaleva, I.M. Schmidt, M. Chellakooty, H.E. Virtanen, K.A. Boisen, I.N. Damgaard, C.M. Kai, N.E. Skakkebaek, J. Toppari, Hormonal changes in 3-month-old cryptorchid boys. J. Clin. Endocrinol. Metab. 91, 953–958 (2006)
D. Cortes, E. Clasen-Linde, J.M. Hutson, R. Li, J. Thorup, The sertoli cell hormones inhibin-B and anti Müllerian hormone have different patterns of secretion in prepubertal cryptorchid boys. J. Pediatr. Surg. 51, 475–480 (2016)
B. Fallon, T.J. Kennedy, Long-term follow-up of fertility in cryptorchid patients. Urology 25, 502–504 (1985)
M. Cendron, M.A. Keating, D.S. Huff, C.E. Koop, H.M. Snyder 3rd, J.W. Duckett, Cryptorchidism, orchiopexy and infertility: a critical long-term retrospective analysis. J. Urol. 142, 559–562 (1989)
A. Okuyama, N. Nonomura, M. Nakamura, M. Namiki, H. Fujioka, H. Kiyohara, K. Matsumoto, T. Sonoda, Surgical management of undescended testis: retrospective study of potential fertility in 274 cases. J. Urol. 142, 749–751 (1989)
H. Yavetz, B. Harash, G. Paz, L. Yogev, A.J. Jaffa, J.B. Lessing, Z.T. Homonnai, Cryptorchidism: incidence and sperm quality in infertile men. Andrologia 24, 293–297 (1992)
S. D’Agostino, F. Zen, E. Ioverno, C. Pesce, G. Belloli, Cryptorchidism and fertility: evaluation in adult age. Pediatr. Med. Chir. 18, 37–40 (1996)
P.A. Lee, M.T. Coughlin, Fertility after bilateral cryptorchidism. Evaluation by paternity, hormone, and semen data. Horm. Res. 55, 28–32 (2001)
J.M. Hutson, A. Balic, T. Nation, B. Southwell, Cryptorchidism. Semin. Pediatr. Surg. 19, 215–224 (2010)
F. Hadziselimovic, B. Herzog, The importance of both an early orchidopexy and germ cell maturation for fertility. Lancet 358, 1156–1157 (2001)
A. Zorgniotti, Temperature and environmental effects on the testis. Adv. Exp. Med. Biol. 286, 1–335 (1991)
R. Mieusset, P. Fonda, P. Vaysse, J. Guitard, J. Moscovici, S. Juskiewenski, Increase in testicular temperature in case of cryptorchidism in boys. Fertil. Steril. 59, 1319–1321 (1993)
D.S. Huff, F. Hadziselimovic, H.M. Snyder III, B. Blythe, J.W. Ducket, Histologic maldevelopment of unilaterally cryptorchid testes and their descended partners. Eur. J. Pediatr. 52, 11–14 (1993)
D.S. Huff, D.M. Fenig, D.A. Canning, M.G. Carr, S.A. Zderic, H.M. Snyder 3rd, Abnormal germ cell development in cryptorchidism. Horm. Res. 55, 11–17 (2001)
E.M. Ritzén, A. Bergh, R. Bjerknes, P. Christiansen, D. Cortes, S.E. Haugen, N. Jörgensen, C. Kollin, S. Lindahl, G. Läckgren, K.M. Main, A. Nordenskjöld, E. Rajpert-De Meyts, O. Söder, S. Taskinen, A. Thorsson, J. Thorup, J. Toppari, H. Virtanen, Nordic consensus on treatment of undescended testes. Acta Paediatr. 96, 638–643 (2007)
M.J. Mathers, H. Sperling, H. Rübben, S. Roth, The undescended testis: diagnosis, treatment and long-term consequences. Dtsch Arztebl Int 106, 527–532 (2009)
C.J. Bradshaw, G. Corbet-Burcher, R. Hitchcock, Age at orchidopexy in the UK: has new evidence changed practice? J. Pediatr. Urol. 10, 758–762 (2014)
K.O. Hensel, T. Caspers, A.C. Jenke, E. Schuler, S. Wirth, Operative management of cryptorchidism: guidelines and reality- a 10-year observational analysis of 3587 cases. BMC Pediatr. 15, 116 (2015)
J. Gracia, J. Sánchez Zalabardo, J. Sánchez García, C. García, A. Ferrández, Clinical, physical, sperm and hormonal data in 251 adults operated on for cryptorchidism in childhood. BJU Int. 85, 1100–1103 (2000)
M.T. Coughlin, M.F. Bellinger, P.A. Lee, Age at unilateral orchiopexy: effect on hormone levels and sperm count in adulthood. J. Urol. 162, 986–989 (1999)
G.E. Tasian, A.B. Hittelman, G.E. Kim, M.J. DiSandro, L.S. Baskin, Age at orchiopexy and testis palpability predict germ and Leydig cell loss: clinical predictors of adverse histological features of cryptorchidism. J. Urol. 182, 704–709 (2009)
D.T. Bica, F. Hadziselimovic, Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study. J. Urol. 148, 617–621 (1992)
C. Spinelli, S. Strambi, M. Busetto, V. Pucci, F. Bianco, Effects on normalized testicular atrophy index (TAIn) in cryptorchid infants treated with GnRHa pre and post-operative vs surgery alone: a prospective randomized trial and long-term follow-up on 62 cases. Pediatr. Surg. Int. 30, 1061–1067 (2014)
H.M. Behre, D. Nashan, E. Nieschlag, Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. Int. J. Androl. 12, 395–403 (1989)
A. Vermeulen, L. Verdonck, J.M. Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 84, 3666–3672 (1999)
World Health Organisation (WHO). Laboratory Manual for the Examination and Processing of Human Semen. 5th edn. World Health Organization, Geneva. (2010)
J. Regadera, J. Codesal, R. Paniagua, P. Gonzalez-Peramato, M. Nistal, Immunohistochemical and quantitative study of interstitial and intratubular Leydig cells in normal men, cryptorchidism, and Klinefelter’s syndrome. J. Pathol. 164, 299–306 (1991)
J.J. Sirvent, R. Bernat, J. Rodriguez Tolra, M.A. Navarro, B. Garcia, J. Brunet, Postpubertal cryptorchism. Morphofunctional study with special reference to Leydig’s cells. Eur. Urol. 16, 433–439 (1989)
P.A. Lee, M.T. Coughlin, Leydig cell function after cryptorchidism: evidence of the beneficial result of early surgery. J. Urol. 167, 1824–1827 (2002)
F. Hadziselimovic, B. Hoecht, Testicular histologyrelated to fertility outcome and postpubertal hormonal status in cryptorchidism. Klin Pädiatr 219, 1–6 (2008)
F. Hadziselimovic, L.R. Emmons, M.W. Buser, A diminished postnatal surge of Ad spermatogonia in cryptorchid infants is additional evidence for hypogonadotropic hypogonadism. Swiss. Med. Wkly. 134, 381–384 (2004)
F.J. Hayes, S.B. Seminara, S. DeCruz, P.A. Boepple, W.F. Crowley Jr, Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J. Clin. Endocrinol. Metab. 85, 3027–3035 (2000)
V. Rochira, L. Zirilli, A.D. Genazani, A. Balestrieri, C. Aranda, B. Fabre, P. Antunez, C. Diazzi, C. Carani, L. Maffei, Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. Eur. J. Endocrinol. 155, 513–522 (2006)
F. Hadziselimovic, B. Hoecht, Testicular histology related to fertility outcome and postpubertal hormone status in cryptorchidism. Klin. Padiatr. 220, 302–307 (2008)
P.A. Lee, L.A. O’Leary, N.J. Songer, M.T. Coughlin, M.F. Bellinger, R.E. LaPorte, Paternity after bilateral cryptorchidism: a controlled study. Arch. Pediatr. Adolesc. Med. 151, 260–263 (1997)
S. Sadov, J.J. Koskenniemi, H.E. Virtanen, A. Perheentupa, J.H. Petersen, N.E. Skakkebaek, K.M. Main, J. Toppari, Testicular growth during puberty in boys with and without a history of congenital cryptorchidism. J. Clin. Endocrinol. Metab. 6, jc20153329 (2016)
C. Kollin, B. Karpe, U. Hesser, T. Granholm, E.M. Ritzén, Surgical treatment of unilaterally undescended testes: testicular growth after randomization to orchiopexy at age 9 months or 3 years. J. Urol. 178, 1589–1593 (2007)
C. Kollin, J.B. Stukenborg, M. Nurmio, E. Sundqvist, T. Gustafsson, O. Söder, J. Toppari, A. Nordenskjöld, E.M. Ritzén, Boys with undescended testes: endocrine, volumetric and morphometric studies on testicular function before and after orchidopexy at nine months or three years of age. J. Clin. Endocrinol. Metab. 97, 4588–4595 (2012)
A.M. Andersson, N. Jørgensen, L. Frydelund-Larsen, E. Rajpert-De Meyts, N.E. Skakkebaek, Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls. J. Clin. Endocrinol. Metab. 89, 3161–3167 (2004)
R. Romeo, M.F. Marcello, Some considerations on the human Leydig cell (immunohistochemical observations). Arch. Ital. Urol. Androl. 71, 143–148 (1999)
D. Clarnette, D. Rowe, S. Hasthorpe, J.M. Hutson, Incomplete disappearance of the processus vaginalis as a cause of ascending testis. J. Urol. 157, 1889–1891 (1997)
Acknowledgments
We thank the technical staff: Sabine Forsthoff for hormone analyses, and Raphaele Kürten, Daniela Hanke, Sabine Rehr, Jolanta Körber for semen analyses and Susan Nieschlag M.A. for language editing of the manuscript. We thank Manuela Simoni for her support of this project and Frank Tüttelmann for database support.
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. A. Luberto received an educational grant from her home institution, the University of Modena.
Author Contributions
JR designed the study, was involved in patient care, assembled data, performed data evaluation and drafted the manuscript. AL assembled data, contributed to data evaluation and drafting of the manuscript. EN was the head of the institution until 2008, was involved in patient management and edited the manuscript. MZ designed the study, was involved in patient care and edited the manuscript. SK is the head of the department since 2008, initiated the study, was involved in patient management and edited the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Rohayem, J., Luberto, A., Nieschlag, E. et al. Delayed treatment of undescended testes may promote hypogonadism and infertility. Endocrine 55, 914–924 (2017). https://doi.org/10.1007/s12020-016-1178-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1178-0